Medicaid recipients are a low-income population that disproportionately experiences opioid overdoses, so access to low- or no-cost naloxone through insurance can help to save lives. A new study led by ...
The rapid expansion of the federal 340B drug pricing program is significantly affecting Medicaid budgets, particularly in states where managed care plans oversee prescription drug benefits. New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results